Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Centro Cardiologico Monzino
With
This is a prospective, multicenter, non-profit observational study enrolling adult patients diagnosed with hypertrophic cardiomyopathy (HCM) who undergo cardiac magnetic resonance (CMR) imaging as part of routine clinical practice. The study aims to evaluate the role of CMR radiomics in predicting arrhythmic risk in patients with HCM and to investigate phenotypic evolution in patients with obstructive hypertrophic cardiomyopathy (oHCM) treated with Mavacamten. Specifically, the study will assess whether radiomic features extracted from CMR imaging can improve the identification of patients at risk of malignant ventricular arrhythmic events and whether radiomic analysis can detect phenotypic modifications associated with mavacamten treatment that may contribute to longitudinal reassessment of arrhythmic risk. Eligible participants will include adult patients with a diagnosis of hypertrophic cardiomyopathy, including both obstructive and non-obstructive forms, who undergo clinically indicated CMR examinations. In addition, the study will include a subgroup of patients with obstructive HCM initiating treatment with mavacamten, for whom both baseline CMR assessment and longitudinal follow-up CMR evaluation will be available. Approximately 2,000 patients are expected to be enrolled in the study. Clinical data, standard CMR parameters, and radiomic features extracted from imaging sequences will be collected and analyzed in order to develop predictive models for arrhythmic risk stratification and to evaluate potential imaging biomarkers associated with disease progression and treatment-related phenotypic changes.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
